Navigation Links
Hoag Breast Care Center First in California to Offer 3D Mammography
Date:9/21/2011

NEWPORT BEACH, Calif., Sept. 21, 2011 /PRNewswire/ -- Hoag Memorial Hospital Presbyterian announced today that Hoag Breast Care Center is the first breast care center in California and one of only a handful in the United States to offer 3D digital breast tomosynthesis for breast cancer screening. This revolutionary technology promises to improve breast cancer detection, especially in young women and women of any age with radiographically dense breast tissue. Women who undergo routine mammograms at Hoag Breast Care Center now have the latest screening technology available to them.

Digital breast tomosynthesis (DBT) is an FDA-approved 3D imaging modality that gives radiologists the ability to identify and characterize individual breast structures without the confusion of overlapping tissue, the Achilles heel of 2D digital mammography.  Breast tomosynthesis is especially beneficial for women with dense breasts. Dense breast tissue can obscure an underlying cancer, or conversely mimic a cancer when none exists. Approximately 15 to 20 percent of breast cancers cannot be detected using traditional 2D mammography, especially in women with dense breast tissue.

"It's a major milestone to be the first breast center in California to provide patients with digital breast tomosynthesis," said Gary M. Levine, M.D., director of breast imaging at Hoag Breast Care Center and one of the nation's leading experts in breast tomosynthesis. "At Hoag we have been involved with the development and testing of tomosynthesis since 2009. Recent reader studies have confirmed digital breast tomosynthesis to be superior to conventional mammography alone at finding early breast cancer. Tomosynthesis will allow us to discover more early stage breast cancers, and early detection translates to lives saved."

During a tomosynthesis exam, 15 digital "projection" images are captured as it arcs over the breast, during a short four-second scan. These images are then digitally r
'/>"/>

SOURCE Hoag Memorial Hospital Presbyterian
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
7. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
8. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
9. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
10. Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
11. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... we bring you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. ... Medicare resources and continue highlighting the success of the prescription drug benefit, commonly referred ... out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... Calif. , July 30, 2015  Amgen (NASDAQ: ... , partner and managing director of Warburg Pincus LLC, to ... pleased to welcome Fred Hassan and the deep, ... Amgen Board," said Robert A. Bradway , chairman and ... commitment to innovation will serve Amgen well." Mr. ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... On March 11, 2011, the United States District ... as to a portion of the patent litigation brought ... and its wholly-owned subsidiary CIMA Labs, Inc., ("CIMA") against ... Inc., (collectively "Watson") pertaining to Cephalon,s FENTORA® fentanyl buccal ...
... 2011 SCOLR Pharma, Inc. (OTC Bulletin Board: ... letter from the Food and Drug Administration (FDA) identifying ... extended-release pseudoephedrine.   The Company said the ... had with the conduct of the bioequivalence study submitted ...
Cached Medicine Technology:Court Rules on First Set of Patents in FENTORA Litigation 2SCOLR Pharma, Inc. Receives Deficiency Letter from FDA on Pseudoephedrine Application 2
(Date:7/31/2015)... Chicago, IL (PRWEB) , ... July 31, 2015 , ... ... which is currently going on in Chicago at Grant Park. The festival ... every corner of North America to Chicago for the annual Lollapalooza. This unique ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... industry players to know in predictive health analytics , Jvion continues to ... The firm creates predictive software that targets patient and population level illness to ...
(Date:7/31/2015)... ... , ... The 2nd annual Ride to Fight On will start and end ... The Ride to Fight On is a cycling fundraiser that benefits the West Cancer ... and The University of Tennessee Health Science Center. A health and wellness festival featuring ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... There’s ... as possible, even when it comes time to cook the next meal, making July ... of July by practicing best grilling tips and recipes. , Make the next cookout ...
(Date:7/31/2015)... ... 31, 2015 , ... Facebook, Twitter, Linkedin and blogs are ... media profiles to better connect with the public. The agency website at ... insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ways ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... EAST LANSING, Mich. Scientists at Michigan State University ... that trigger inflammation in the mammary gland. ... increasing the risk of breast cancer. Progesterone is ... the normal mammary gland. Progesterone previously has been identified ...
... 19, 2009) Scientists from the U.S. Department of ... Chicago,s Brain Tumor Center have developed a way to ... nanoparticles bonded to soft biological material. Thousands of ... the tumors are resistant to conventional therapies. This nano-bio ...
... , , TAMPA, Fla., Aug. ... People for the Ethical Treatment of Animals (PETA) to immediately end ... image and portrayal of obese/overweight individuals. The OAC believes this campaign ... their size or weight. , , The campaign ...
... , WASHINGTON, Aug. 19 Following ... , , The "Bulletin," which is free of ... you the latest issues and news affecting people with disabilities. To ... on "Online mailing list archives," select "NCD-NEWS-L," click on "Join or ...
... ... part of the new series of standard hybrid stepper motors presented by NMB. These popular ... ... announced today the availability of a new line of standard hybrid stepper motors. , , ...
... , , PACE(R) Programs Open Doors ... WASHINGTON, Aug. 19 In celebration of National Senior ... working with many of the individual Programs of All-inclusive Care for ... about PACE through health fairs and open houses. Designed to ...
Cached Medicine News:Health News:MSU scientists: Progesterone leads to inflammation 2Health News:Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials 2Health News:Obesity Action Coalition Calls on PETA to Immediately End Campaign Stigmatizing Overweight and Obese Individuals 2Health News:National Council on Disability Monthly Bulletin for August 2009 2Health News:National Council on Disability Monthly Bulletin for August 2009 3Health News:National Council on Disability Monthly Bulletin for August 2009 4Health News:National Council on Disability Monthly Bulletin for August 2009 5Health News:National Council on Disability Monthly Bulletin for August 2009 6Health News:National Council on Disability Monthly Bulletin for August 2009 7Health News:NMB's New Series of Standard Hybrid Stepper Motors Now Available 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 2Health News:National Senior Citizens Day Celebrated August 21 Amid Health Care Reform Debate 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: